Abstract
Background: Nowadays, there is an accumulated data about the relation between hypomagnesemia (low Serum Mg level < 0.7 mmol/l) and diabetes.
Objective: In this study, we aimed to determine the prevalence of hypomagnesemia in a carefully diagnosed diabetes patients and to show how some factors could contribute to the prevalence of low serum Mg level among the population under study.
Methods: In short, 62 patients of both type 1 and 2, who attended AL-Sadir medical city/ diabetes and endocrinology centre during the period of the study were included in the study. A detailed history was taken and participants were informed verbally about the procedure of this study. Serum magnesium and creatinine were measured using standardized methods.
Results: The overall prevalence of the hypomagnesemia, among diabetic population involved in this study, was 29.03 % and it was nearly similar in male (29.41 %) and female (28.57 %). The means(SD) of serum Mg level were similar in type 1 and type 2 diabetic patients. Other difference in prevalence among other characteristics has been reported. Within all participants, gender (r = -0.02), fasting blood glucose (r = -0.514) and metformin use (r = -0.014) were negatively correlated with serum Mg level, in contrast to other variables, which were positively correlated. While among type 1 DM, age (r= 0.193), serum creatinine (r= 0.031) and insulin use (r= 0.217) were positively correlated with serum Mg level. In contrast, others were negatively correlated. In type 2 DM, age (r = -0.283) and fasting blood glucose (r = -0.496) were negatively correlated with serum Mg level. On the other hand, other variables were positively correlated with serum Mg level.
Conclusion: Hypomagnesemia prevalence was detected in nearly one-third of the diabetic population, which is quite high prevalence. Some factors have shown to play an essential role in this prevalence. A large study is warranted to address this issue.
Keywords: Hypomagnesemia, diabetes mellitus, magnesium ion, patients, metformin, serum creatinine, standard deviation.
[http://dx.doi.org/10.12998/wjcc.v2.i10.488] [PMID: 25325058]
[http://dx.doi.org/10.1056/NEJMra1503102] [PMID: 26244308]
[http://dx.doi.org/10.3390/nu7095388] [PMID: 26404370]
[http://dx.doi.org/10.1530/EJE-16-0517] [PMID: 27707767]
[http://dx.doi.org/10.1097/MCO.0000000000000410] [PMID: 28806179]
[http://dx.doi.org/10.1016/j.dsx.2014.04.024] [PMID: 25470649]
[http://dx.doi.org/10.1093/ndtplus/sfr163] [PMID: 26069819]
[http://dx.doi.org/10.1007/s00125-017-4224-4] [PMID: 28224192]
[http://dx.doi.org/10.2337/db15-1028] [PMID: 26696633]
[http://dx.doi.org/10.1159/000468530] [PMID: 28297698]
[http://dx.doi.org/10.3390/nu8110739] [PMID: 27869762]
[http://dx.doi.org/10.2337/dc13-1397] [PMID: 24089547]
[http://dx.doi.org/10.1097/MOL.0b013e3282f33ccc] [PMID: 18196987]
[PMID: 18507265]
[http://dx.doi.org/10.3109/03014460.2010.500472] [PMID: 20626252]
[http://dx.doi.org/10.5812/ijem.17796] [PMID: 25237327]
[http://dx.doi.org/10.4236/ojpm.2018.83006]